Prospective randomized crossover trial of combination therapy with bezafibrate and UDCA for primary biliary cirrhosis
β Scribed by Jun Itakura; Namiki Izumi; Yuki Nishimura; Kazunari Inoue; Ken Ueda; Hiroyuki Nakanishi; Kaoru Tsuchiya; Kosei Hamano; Yasuhiro Asahina; Masayuki Kurosaki; Masakatsu Uchihara; Shozo Miyake
- Book ID
- 108138189
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 108 KB
- Volume
- 29
- Category
- Article
- ISSN
- 1386-6346
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Fatigue is common in primary biliary cirrhosis (PBC). Altered central serotonergic neurotransmission may be involved in its pathogenesis. This multicenter, randomized, double-blind, placebo-controlled, crossover trial evaluated the efficacy of ondansetron, a selective 5-HT3 receptor subtype antagoni
## Abstract ## BACKGROUND To the authors' knowledge, the significance of postoperative adjuvant chemotherapy in pancreaticobiliary carcinoma has not yet been clarified. A randomized controlled study evaluated the effect of postoperative adjuvant therapy with mitomycin C (MMC) and 5βfluorouracil (5